Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10101
CALL
Direxion Daily S&P 500 High Beta Bear 3X ETF
HIBS
$17.4M
| $236K | ﹤0.01% |
+1,240
| New | +$225K |
|
|
XNET
10102
Xunlei
XNET
$334M
| $236K | ﹤0.01% |
118,399
+45,858
| +63% | +$93K |
|
10103
CALL
SELLAS Life Sciences
SLS
$2.58B
| $235K | ﹤0.01% |
226,400
+63,600
| +39% | +$72.6K |
|
10104
PUT
Fidus Investment
FDUS
$744M
| $235K | ﹤0.01% |
11,200
+1,200
| +12% | +$24.3K |
|
10105
Doximity
DOCS
$4.42B
| $235K | ﹤0.01% |
4,407
-40,214
| -90% | -$1.97M |
|
10106
CALL
Sera Prognostics
SERA
$77.3M
| $235K | ﹤0.01% |
+28,900
| New | +$212K |
|
|
ONTF
10107
DELISTED
ON24
ONTF
| $235K | ﹤0.01% |
36,401
+7,640
| +27% | +$49K |
|
10108
PUT
Flywire
FLYW
$2.29B
| $235K | ﹤0.01% |
11,400
-12,300
| -52% | -$240K |
|
10109
ProShares Short Real Estate
REK
$11.7M
| $235K | ﹤0.01% |
13,497
+2,316
| +21% | +$38.7K |
|
10110
CALL
U-Haul Holding Co
UHAL
$14.4B
| $235K | ﹤0.01% |
3,400
-1,300
| -28% | -$94.3K |
|
10111
CALL
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.97B
| $235K | ﹤0.01% |
5,800
+900
| +18% | +$38K |
|
10112
PUT
PTC Therapeutics
PTCT
$5.98B
| $235K | ﹤0.01% |
5,200
-500
| -9% | -$21.4K |
|
10113
CALL
Manitowoc
MTW
$746M
| $235K | ﹤0.01% |
25,700
+15,900
| +162% | +$157K |
|
10114
ActivePassive US Equity ETF
APUE
$2.52B
| $235K | ﹤0.01% |
+6,561
| New | +$238K |
|
10115
PUT
Acushnet Holdings
GOLF
$5.26B
| $235K | ﹤0.01% |
3,300
+200
| +6% | +$13.6K |
|
10116
CALL
MBIA
MBI
$264M
| $234K | ﹤0.01% |
36,300
-15,000
| -29% | -$77.3K |
|
10117
CALL
State Street SPDR S&P Capital Markets ETF
KCE
$480M
| $234K | ﹤0.01% |
1,700
+800
| +89% | +$111K |
|
10118
Village Super Market
VLGEA
$637M
| $234K | ﹤0.01% |
+7,339
| New | +$229K |
|
10119
Laird Superfood
LSF
$52.7M
| $234K | ﹤0.01% |
+29,700
| New | +$227K |
|
10120
CALL
SelectQuote
SLQT
$129M
| $234K | ﹤0.01% |
62,900
+16,300
| +35% | +$41.6K |
|
10121
Duluth Holdings
DLTH
$153M
| $234K | ﹤0.01% |
75,617
-22,788
| -23% | -$82.8K |
|
10122
CALL
Rekor Systems
REKR
$98.2M
| $233K | ﹤0.01% |
149,500
+128,700
| +619% | +$134K |
|
10123
PUT
Aquestive Therapeutics
AQST
$533M
| $233K | ﹤0.01% |
65,500
+5,400
| +9% | +$24.9K |
|
|
DAWN
10124
CALL
DELISTED
Day One Biopharmaceuticals
DAWN
| $233K | ﹤0.01% |
18,400
+8,800
| +92% | +$122K |
|
|
NAK
10125
Northern Dynasty Minerals
NAK
$908M
| $233K | ﹤0.01% |
+400,894
| New | +$179K |
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,423 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.